Advances in multimodal data fusion in neuroimaging: overview, challenges, and novel orientation
Multimodal fusion in neuroimaging combines data from multiple imaging modalities to
overcome the fundamental limitations of individual modalities. Neuroimaging fusion can …
overcome the fundamental limitations of individual modalities. Neuroimaging fusion can …
PET parametric imaging: past, present, and future
Positron emission tomography (PET) is actively used in a diverse range of applications in
oncology, cardiology, and neurology. The use of PET in the clinical setting focuses on static …
oncology, cardiology, and neurology. The use of PET in the clinical setting focuses on static …
Fibroblast activation protein–specific PET/CT imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study
M Röhrich, D Leitz, FM Glatting, AK Wefers… - Journal of nuclear …, 2022 - Soc Nuclear Med
Interstitial lung diseases (ILDs) comprise over 200 parenchymal lung disorders. Among
them, fibrosing ILDs, especially idiopathic pulmonary fibrosis, are associated with a poor …
them, fibrosing ILDs, especially idiopathic pulmonary fibrosis, are associated with a poor …
First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients
Purpose To investigate the kinetics of 18 F-fluorodeoxyglucose (18 F-FDG) by positron
emission tomography (PET) in multiple organs and test the feasibility of total-body …
emission tomography (PET) in multiple organs and test the feasibility of total-body …
Fibrometabolism—An emerging therapeutic frontier in pulmonary fibrosis
B Selvarajah, I Azuelos, D Anastasiou… - Science Signaling, 2021 - science.org
Fibrosis is the final pathological outcome and major cause of morbidity and mortality in many
common and chronic inflammatory, immune-mediated, and metabolic diseases. Despite the …
common and chronic inflammatory, immune-mediated, and metabolic diseases. Despite the …
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis
PT Lukey, SA Harrison, S Yang, Y Man… - European …, 2019 - Eur Respiratory Soc
Phosphatidylinositol 3-kinases (PI3Ks) and mammalian target of rapamycin (mTOR) play a
role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Omipalisib (GSK2126458) is …
role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Omipalisib (GSK2126458) is …
[HTML][HTML] Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)
Purpose There is a lack of prognostic biomarkers in idiopathic pulmonary fibrosis (IPF)
patients. The objective of this study is to investigate the potential of 18 F-FDG-PET/CT to …
patients. The objective of this study is to investigate the potential of 18 F-FDG-PET/CT to …
High-temporal-resolution lung kinetic modeling using total-body dynamic PET with time-delay and dispersion corrections
Tracer kinetic modeling in dynamic PET has the potential to improve the diagnosis,
prognosis, and research of lung diseases. The advent of total-body PET systems with much …
prognosis, and research of lung diseases. The advent of total-body PET systems with much …
Quantification of lung PET images: challenges and opportunities
Millions of people are affected by respiratory diseases, leading to a significant health burden
globally. Because of the current insufficient knowledge of the underlying mechanisms that …
globally. Because of the current insufficient knowledge of the underlying mechanisms that …
[HTML][HTML] 18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
E Ledoult, M Morelle, M Soussan, A Mékinian… - Arthritis Research & …, 2021 - Springer
Background Interstitial lung disease is a common complication of systemic sclerosis (SSc-
ILD), and it remains difficult to accurately predict its course. Progressing ILD could be more …
ILD), and it remains difficult to accurately predict its course. Progressing ILD could be more …